Rémi Buisson
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- RNA modifications and cancer
Papers in ⓘ
-
- DNA Repair Mechanisms 20
- CRISPR and Genetic Engineering 11
- Genomics and Chromatin Dynamics 7
- RNA Research and Splicing 7
- RNA modifications and cancer 6
- RNA regulation and disease 5
- Co-authors
- Lee Zou (11 shared papers)Cyril H. Benes (4 shared papers)Jean‐Yves Masson (14 shared papers)Hai Dang Nguyen (2 shared papers)Michael S. Lawrence (7 shared papers)Lilian Kabeche (1 shared paper)Jessica L. Boisvert (1 shared paper)Bing Xia (3 shared papers)
- Journals
- Nature Communications (8 papers)Nucleic Acids Research (4 papers)Cancer Research (4 papers)Molecular Cell (3 papers)Nature Structural & Molecular Biology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Rémi Buisson
42 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 80
- Oncology 923
- Molecular Biology 2.2k
- Cancer Research 397
- Aging 30
- Virology 66
Countries citing papers authored by Rémi Buisson
This map shows the geographic impact of Rémi Buisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Buisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Buisson more than expected).
Fields of papers citing papers by Rémi Buisson
This network shows the impact of papers produced by Rémi Buisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Buisson. The network helps show where Rémi Buisson may publish in the future.
Co-authors
The 25 scholars most cited alongside Rémi Buisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 306 | |
| 2 | 2017 | 302 | |
| 3 | 2010 | 236 | |
| 4 | 2017 | 232 | |
| 5 | 2015 | 226 | |
| 6 | 2019 | 181 | |
| 7 | 2017 | 142 | |
| 8 | 2017 | 95 | |
| 9 | 2009 | 93 | |
| 10 | 2014 | 72 | |
| 11 | 2020 | 70 | |
| 12 | 2021 | 68 | |
| 13 | 2021 | 55 | |
| 14 | 2012 | 47 | |
| 15 | 2011 | 45 | |
| 16 | 2018 | 42 | |
| 17 | 2021 | 40 | |
| 18 | 2019 | 32 | |
| 19 | 2016 | 29 | |
| 20 | 2012 | 29 |
About Rémi Buisson
Rémi Buisson is a scholar working on Cancer Research, Molecular Biology, Aging, Oncology and Immunology, having authored 44 papers that have together received 2.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (20 papers), CRISPR and Genetic Engineering (11 papers), PARP inhibition in cancer therapy (9 papers), Genomics and Chromatin Dynamics (7 papers), RNA Research and Splicing (7 papers), RNA modifications and cancer (6 papers), RNA regulation and disease (5 papers) and interferon and immune responses (5 papers). The work is most often cited by research in Oncology (923 citations), Molecular Biology (2.2k citations), Cancer Research (397 citations), Aging (30 citations) and Virology (66 citations). Rémi Buisson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lee Zou, Cyril H. Benes, Jean‐Yves Masson, Hai Dang Nguyen, Michael S. Lawrence, Lilian Kabeche, Jessica L. Boisvert, Bing Xia, Adam Langenbucher and Yan Coulombe. Their work appears in journals such as Nature Communications, Nucleic Acids Research, Cancer Research, Molecular Cell and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.